open access

Vol 2, No 1 (2013)
Review article
Submitted: 2013-04-10
Accepted: 2013-04-10
Published online: 2013-04-10
Get Citation

Treatment of dyslipidemia in diabetes — individualization of therapeutic strategies

Barbara Idzior-Waluś, Małgorzata Waluś-Miarka
DOI: 10.5603/cd.34007
·
Diabetologia Kliniczna 2013;2(1):23-29.

open access

Vol 2, No 1 (2013)
Review
Submitted: 2013-04-10
Accepted: 2013-04-10
Published online: 2013-04-10

Abstract

In this paper treatment recommendations of diabetic
dyslipidemia are presented, based on PTD guidelines.
The goal of treatment in patients with diabetes
is to decrease LDL-cholesterol level below 2.6 mmol/l
and in patients with diabetes and cardiovascular
disease below 1.8 mmol/l. Desirable values of HDL-C
is > 1.3 mmol/l in women and > 1.0 mmol/l in men,
and of triglycerides < 1.7 mmol/l. Statin is fi rst line
treatment; if targets are not reached combined therapy
with other lipid lowering drugs may be considered, but
this therapy has not been evaluated in CVD and safety
outcome studies.

Abstract

In this paper treatment recommendations of diabetic
dyslipidemia are presented, based on PTD guidelines.
The goal of treatment in patients with diabetes
is to decrease LDL-cholesterol level below 2.6 mmol/l
and in patients with diabetes and cardiovascular
disease below 1.8 mmol/l. Desirable values of HDL-C
is > 1.3 mmol/l in women and > 1.0 mmol/l in men,
and of triglycerides < 1.7 mmol/l. Statin is fi rst line
treatment; if targets are not reached combined therapy
with other lipid lowering drugs may be considered, but
this therapy has not been evaluated in CVD and safety
outcome studies.
Get Citation

Keywords

diabetic dyslipidemia, diabetes, statins

About this article
Title

Treatment of dyslipidemia in diabetes — individualization of therapeutic strategies

Journal

Clinical Diabetology

Issue

Vol 2, No 1 (2013)

Article type

Review article

Pages

23-29

Published online

2013-04-10

Page views

604

Article views/downloads

5984

DOI

10.5603/cd.34007

Bibliographic record

Diabetologia Kliniczna 2013;2(1):23-29.

Keywords

diabetic dyslipidemia
diabetes
statins

Authors

Barbara Idzior-Waluś
Małgorzata Waluś-Miarka

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl